FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

41145411000001103: Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Nov 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
243601000001118 Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
243621000001113 Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Is a Co-codamol 30mg/500mg effervescent tablets 100 tablet true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Has AMP Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient Codeine phosphate true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Has dispensed dose form Conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg effervescent tablets (Cipla EU Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start